Skip links

Litigation Update: $40 Million Verdict Against Johnson & Johnson in Talc Trial

Litigation Update: $40 Million Verdict Against Johnson & Johnson in Talc Trial

On Friday, September 27, a woman suffering from mesothelioma, a cancer linked to asbestos exposure, and her husband were  awarded $40.3 million by a California jury. Nancy Cabibi, 71, was a regular user of Johnson’s Baby Powder and Shower To Shower talc products, both of which are manufactured by J&J; according to documents filed with the court, testing done of Ms. Cabibi’s body tissue revealed the presence of tremolite and anthophyllite asbestos which her attorneys argued were known to be in both products.

In its assessment, the jury determined that the presence of the asbestos rendered the J&J products defective, that the products were a substantial factor in Ms. Cabibi developing mesothelioma and that the company knew of the risks but failed to warn the plaintiff and other consumers. The jury did not find that J&J’s talcum products were negligently designed or that the company had acted with malice or fraud, as plaintiffs’ counsel had argued.

Click on this link for information on Verus’ Case Management and Medical Review Services. To contact us, fill out this form or email us at info@verusllc.com and we will reply immediately.

|CONTACT US| |REQUEST PROPOSAL|

Join the Discussion